FibroBiologics Presents Data from Dermal Fibroblast Spheroid

FibroBiologics Presents Data from Dermal Fibroblast Spheroid-based Treatment of Chronic Wounds in a Diabetes Mouse Model at Advanced Wound Care Summit USA

HOUSTON, April 04, 2024 -- FibroBiologics, Inc., , a clinical-stage biotechnology company with 150+ patents issued and pending for the development of therapeutics and potential cures for chronic...

Related Keywords

United States , Boston , Massachusetts , Houston , Texas , Liz Phillips , Subhiksha Raghuram , Harrison Seidner , Fibrobiologics Inc , Nasdaq , Advanced Wound Care Summit United States , Fibrobiologic Chief Scientific Officer , Hamid Khoja , Diabetic Mouse , Chief Scientific Officer , Dermal Fibroblast Spheroid Based Treatment , Chronic Wounds , Diabetes Mouse , Associate Scientist , Private Securities Litigation Reform Act , Markets ,